Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants

NCT02720328 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Embolism and Thrombosis
Hemorrhage

Interventions

BIOLOGICAL: Blood samples for DOAC measurement

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain